CONTINUING EDUCATION (CE) LANGUAGE

Title: Dysbiosis and Bacterial Overgrowth 

Date: June 25, 2025

Location: Online

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement
NASPGHAN designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABP MOC Part 2 Credits
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.0 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Dysbiosis and small bowel bacterial overgrowth are complications that are seen in patients with gastrointestinal illness, especially those with surgical resections.  The diagnosis of the overgrowth can be difficult to diagnose, and typical testing like breath tests are not as reliable given the patient's altered and shortened anatomy.  This webinar aims to provide up-to-date information on the diagnosis and treatment of bacterial overgrowth, along with its effects and potential risk factors.

CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Management of Pain-Predominant Disorders in Gut-Brain Interaction 

Date:                   June 13, 2025

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Management of Pain-Predominant Disorders in Gut-Brain Interaction, brings together experts from both societies to explore an integrative, global perspective on the treatment of pediatric disorders of gut-brain interaction (DGBI). Attendees will gain insights into both pharmacological and psychological treatment modalities, with a focus on how Eastern and Western approaches can inform and complement one another. The webinar will highlight cutting-edge interventions—ranging from cognitive behavioral therapy to novel medications—and will offer practical strategies for implementation in busy clinical settings. This is a unique opportunity for pediatric GI providers to learn from international leaders and enhance their care for children with pain-predominant DGBI.

Clinical outcomes of maintenance therapy with sulfasalazine compared to 5‐aminosalicylates in children with ulcerative colitis, June 2025 JPGN

CONTINUING EDUCATION (CE) LANGUAGE

Title:                     30,000 Foot View of GI Issues in Children with Neurodevelopmental Disorders 

Date:                    April 30, 2025

Location:              Online 

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.0 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Diagnosing and treating children with neurodevelopmental disorders – including autism, cerebral palsy, and other genetic conditions – presents a unique set of challenges for gastrointestinal disorders. These children often experience a higher prevalence of GI issues which can exacerbate their behavioral and sensory sensitivities. The overlap between GI symptoms and behavioral issues can make it difficult to identify the root cause of distress, complicating diagnosis and treatment.

Communication barriers due to diagnoses, caregiver and patient-imposed dietary restrictions, pediatric feeding disorders and variable growth charts can further complicate nutritional management. Providers need a lower threshold for considering diagnostics and treatment, and the patient may benefit from a collaboration between their provider and behavioral therapists, psychiatrists, neurologists and developmental pediatricians.

This webinar aims to provide high-yield evidence and experience-based practical clinical tools, and will touch on innovation, research, technology and advocacy in this area.

Clinical outcomes of maintenance therapy with sulfasalazine compared to 5‐aminosalicylates in children with ulcerative colitis, June 2025 JPGN

NASPGHAN 2025 guidelines for management of cyclic vomiting syndrome in children, June 2025 JPGN

Join the co-chairs of the NASPGHAN Grants Subcommittee of the Research Committee for an informative session on “how to apply” to the wide variety of NASPGHAN Foundation grants available for all career levels and a variety of topic interests.  Grants range from young investigator and midcareer awards to clinical innovation and pilot grants. Get answers to the most frequently asked questions and learn how to apply for one of the numerous NASPGHAN Foundation grants available in 2025.

Early Management of Acute Caustic Ingestion in Pediatrics; April 2025 JPGN

Low TTG-IgA associated with isolated bulb pathology in pediatric celiac disease: Implications in a no-biopsy approach era April 2025 JPGN

Early Management of Acute Caustic Ingestion in Pediatrics April 2025 JPGN

CONTINUING EDUCATION (CE) LANGUAGE

Title:                     30,000 Foot View of GI Issues in Children with Neurodevelopmental Disorders 

Date:                    April 30, 2025

Location:              Online 

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.0 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

Diagnosing and treating children with neurodevelopmental disorders – including autism, cerebral palsy, and other genetic conditions – presents a unique set of challenges for gastrointestinal disorders. These children often experience a higher prevalence of GI issues which can exacerbate their behavioral and sensory sensitivities. The overlap between GI symptoms and behavioral issues can make it difficult to identify the root cause of distress, complicating diagnosis and treatment.

Communication barriers due to diagnoses, caregiver and patient-imposed dietary restrictions, pediatric feeding disorders and variable growth charts can further complicate nutritional management. Providers need a lower threshold for considering diagnostics and treatment, and the patient may benefit from a collaboration between their provider and behavioral therapists, psychiatrists, neurologists and developmental pediatricians.

This webinar aims to provide high-yield evidence and experience-based practical clinical tools, and will touch on innovation, research, technology and advocacy in this area.